SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-015017
Filing Date
2024-02-16
Accepted
2024-02-16 19:28:57
Documents
2
Period of Report
2024-02-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 12182
2 POWER OF ATTORNEY ea193959ex24_cerotherap.htm EX-24 6873
  Complete submission text file 0001213900-24-015017.txt   20656
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address CERO THERAPEUTICS HOLDINGS, INC. 2201 BROADWAY, SUITE 705 OAKLAND CA 94612
Business Address
Corey Daniel (Reporting) CIK: 0002011547 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40877 | Film No.: 24650150